Skip to main content
. 2021 Mar 26;10:100090. doi: 10.1016/j.metop.2021.100090

Fig. 1.

Fig. 1

Flow chart of the study population (patients included or excluded in the study). Patients developed HCC before SVR or within 3 months after SVR in DAAs group or PR group was 5 out of 533 patients (0.94%) or 11 out of 1202 patients (0.92%), respectively, and there was no significant difference between these two groups (chi-square test, P = 0.963).